Growth Metrics

Sanofi (SNY) Non-Current Deferred Tax Liability (2016 - 2024)

Historic Non-Current Deferred Tax Liability for Sanofi (SNY) over the last 17 years, with Q2 2025 value amounting to $1.9 billion.

  • Sanofi's Non-Current Deferred Tax Liability rose 15.03% to $1.9 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $1.9 billion, marking a year-over-year increase of 15.03%. This contributed to the annual value of $2.3 billion for FY2024, which is 1522.48% up from last year.
  • As of Q2 2025, Sanofi's Non-Current Deferred Tax Liability stood at $1.9 billion, which was up 15.03% from $2.3 billion recorded in Q4 2024.
  • In the past 5 years, Sanofi's Non-Current Deferred Tax Liability registered a high of $2.3 billion during Q4 2024, and its lowest value of $1.7 billion during Q2 2022.
  • Moreover, its 5-year median value for Non-Current Deferred Tax Liability was $1.9 billion (2025), whereas its average is $2.0 billion.
  • In the last 5 years, Sanofi's Non-Current Deferred Tax Liability plummeted by 1795.74% in 2022 and then skyrocketed by 2838.47% in 2023.
  • Sanofi's Non-Current Deferred Tax Liability (Quarter) stood at $1.8 billion in 2021, then increased by 1.54% to $1.9 billion in 2022, then grew by 6.38% to $2.0 billion in 2023, then increased by 15.84% to $2.3 billion in 2024, then decreased by 16.13% to $1.9 billion in 2025.
  • Its Non-Current Deferred Tax Liability was $1.9 billion in Q2 2025, compared to $2.3 billion in Q4 2024 and $1.9 billion in Q2 2024.